Return to Work After Potential Severe Injury

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Completed
CT.gov ID
NCT02602405
Collaborator
St. Olavs Hospital (Other), Statistics Norway (Industry), Namsos Hospital (Other), Helse Nord-Trøndelag HF (Other), Alesund Hospital (Other), Molde Hospital (Other), Kristiansund Hospital (Other)
1,741
8
8
217.6
27.1

Study Details

Study Description

Brief Summary

In Norway an estimated 10 % of the population is injured annually. Of these 36.000 sustain permanent functional impairment, 1.200 receive disability pension, and approximately 2.500 die because of their injuries. Mortality is the most common variable measuring trauma outcome. However, measuring only trauma mortality may be looking merely at the tip of the iceberg. For every trauma death, there are ten-folds suffering long term functional impairment. Mortality is therefore a too crude variable to describe the impact of injuries - both for the individual trauma patient and for society as a whole. There is a need for variables describing long-term outcomes on a functional level. The aim of this study is to use the rate of return to work and education as an alternative outcome measure. The ability of returning to work after injury is a central indicator of individual functional outcome, combining both physical and mental skills in performing complex and compound tasks. Previous studies on return to work after injury are limited by a combination of short follow-up times, the use of patient reported outcomes and having mainly been focusing on only severely injured patients (ISS > 15). This a population-based study including all patients in working age (16

  • 65 years) received by a trauma team in any of the eight hospitals within the region of Central Norway in the time period from June 1st,2007 to May 30th, 2010. Already collected trauma registry data will be linked with national register data on sickness and disability benefits, employment and education.
Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1741 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Return to Work After Potential Severe Injury; a Population Based Observational Study
    Actual Study Start Date :
    Dec 1, 2015
    Actual Primary Completion Date :
    Aug 1, 2016
    Actual Study Completion Date :
    Aug 1, 2016

    Outcome Measures

    Primary Outcome Measures

    1. Return to work [up to 8 years]

    2. Return to education [up to 8 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    16 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • exposed to traumatic injuries

    • received by trauma team attendance

    • received by trauma team activation protocol

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kristiansund Hospital Kristiansund Norway
    2 Levanger Hospital Levanger Norway
    3 Molde Hospital Molde Norway
    4 Namsos Hospital Namsos Norway
    5 Orkanger Hospital Orkanger Norway
    6 St Olavs Hospital Trondheim Norway
    7 Volda Hospital Volda Norway
    8 Ålesund Hospital Ålesund Norway

    Sponsors and Collaborators

    • Norwegian University of Science and Technology
    • St. Olavs Hospital
    • Statistics Norway
    • Namsos Hospital
    • Helse Nord-Trøndelag HF
    • Alesund Hospital
    • Molde Hospital
    • Kristiansund Hospital

    Investigators

    • Study Director: Pål Klepstad, md prof, Norwegian University of Science and Technology

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Norwegian University of Science and Technology
    ClinicalTrials.gov Identifier:
    NCT02602405
    Other Study ID Numbers:
    • 2015/1582
    First Posted:
    Nov 11, 2015
    Last Update Posted:
    Dec 21, 2017
    Last Verified:
    Dec 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Norwegian University of Science and Technology
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 21, 2017